Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 10:37 PM
Ignite Modification Date: 2025-12-25 @ 8:09 PM
NCT ID: NCT01718535
Description: No adverse events were encountered.
Frequency Threshold: 0
Time Frame: Adverse events were monitored for the full duration of the trial (~1 months).
Study: NCT01718535
Study Brief: Method Comparison Study of the Spartan FRX CYP2C19 Genotyping System Against Bi-directional Sequencing
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
*1/*1 CYP2C19 Genotype None None None 0 131 0 131 View
*1/*2 CYP2C19 Genotype None None None 0 95 0 95 View
*2/*2 CYP2C19 Genotype None None None 0 19 0 19 View
*1/*3 CYP2C19 Genotype None None None 0 8 0 8 View
*3/*3 CYP2C19 Genotype None None None 0 1 0 1 View
*1/*17 CYP2C19 Genotype None None None 0 40 0 40 View
*17/*17 CYP2C19 Genotype None None None 0 11 0 11 View
*2/*3 CYP2C19 Genotype None None None 0 6 0 6 View
*2/*17 CYP2C19 Genotype None None None 0 15 0 15 View
*3/*17 CYP2C19 Genotype None None None 0 1 0 1 View
Serious Events(If Any):
Other Events(If Any):